Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASCO 2014 – Colorectal and Head & Neck Cancer
Chemotherapy Plus Bevacizumab or Cetuximab in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Racial Differences in KRAS/BRAF Mutation Rates and Survival in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Early Predictors of Overall Survival in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
The Current Status of Biomarkers in Use for the Treatment of Patients with mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Updated Results of the SOFT Study
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
mCRC Daily News from ASCO 2014: May 30, 2014 - Preview of Key Topics
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Rechallenge with Anti-EGFR Therapy
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
BRAF + MEK Inhibitors in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
BRAF Inhibitor + Cetuximab in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Second-Line Therapies in KRAS–Wild-Type mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma